Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generex Biotechnology Corporation

http://www.generex.com

Latest From Generex Biotechnology Corporation

India CEO Pay: Up, Up For Most, Eye On Gender Pay Gap As Women Execs Rise

C-suite remuneration at leading listed foreign and domestic drug firms in India rose in double digits for the most part in 2022-23, data compiled by Scrip show. While MDs/CEOs at domestic firms continue to take home sizeably higher earnings, the arrival of women leaders at the helm in some foreign firms puts the spotlight on gender pay parity.

Commercial Leadership

Finance Watch: Stark Contrast As Big FOPOs Reach Market, Other Firms Cut Costs

Public Company Edition: Arvinas grossed $350m in a private placement, while Xenon brought in $345m and Pharvaris raised $300m in follow-on public offerings. Fundraising remains challenging, however, so IGM Biosciences, Hansa Biopharma and other companies cut costs to save money.

Financing Business Strategies

Actimed Aims High With Cancer Cachexia Prospect

The UK firm has got the green light in the US to conduct two Phase IIb/III trials of its cancer cachexia candidate S-pindolol but a lot more money needs to be raised to complete them.

Cancer Clinical Trials

Finance Watch: Q2 Saw Fewer, But Larger, Venture Capital Deals

Private Company Edition: Fewer biotech companies raised venture capital in the second quarter, but the amount of capital raised was on par with the first quarter. Also, former BMS R&D exec Rupert Vessey joined Flagship Pioneering, two new VC funds emerged and Septerna raised a $150m series B round.

Financing Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Large Molecule
  • Other Names / Subsidiaries
    • Antigen Express, Inc.
    • Grainland Pharmacy LLC
    • Hema Diagnostic Systems, LLC
    • Medisource Partners
    • NuGenerex Distribution Solutions, LLC
    • NuGenerex Immuno-Oncology
    • Pantheon Medical
    • Pantheon Medical – Foot & Ankle
    • Regentys Corporation
    • Veneto Holdings, LLC
UsernamePublicRestriction

Register